Positive association of collagen type I with non-muscle invasive bladder cancer progression

Michael Brooks, Qianxing Mo, Ross Krasnow, Philip Levy Ho, Yu Cheng Lee, Jing Xiao, Antonina Kurtova, Seth Lerner, Gui Godoy, Weiguo Jian, Patricia Castro, Fengju Chen, David Rowley, Michael Ittmann, Keith Syson Chan

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Abstract

PURPOSE: Non-muscle invasive bladder cancers (NMIBC) are generally curable, while ~15% progresses into muscle-invasive cancer with poor prognosis. While efforts have been made to identify genetic alternations associated with progression, the extracellular matrix (ECM) microenvironment remains largely unexplored. Type I collagen is a major component of the bladder ECM, and can be altered during cancer progression. We set out to explore the association of type I collagen with NMIBC progression. EXPERIMENTAL DESIGN: The associations of COL1A1 and COL1A2 mRNA levels with progression were evaluated in a multi-center cohort of 189 patients with NMIBCs. Type I collagen protein expression and structure were evaluated in an independent single-center cohort of 80 patients with NMIBCs. Immunohistochemical analysis was performed and state-of-the-art multi-photon microscopy was used to evaluate collagen structure via second harmonic generation imaging. Progression to muscle invasion was the primary outcome. Kaplan-Meier method, Cox regression, and Wilcoxon rank-sum were used for statistical analysis. RESULTS: There is a significant association of high COL1A1 and COL1A2 mRNA expression in patients with poor progression-free survival (P=0.0037 and P=0.011, respectively) and overall survival (P=0.024 and P=0.012, respectively). Additionally, immunohistochemistry analysis of type I collagen protein deposition revealed a significant association with progression (P=0.0145); Second-harmonic generation imaging revealed a significant lower collagen fiber curvature ratio in patients with invasive progression (P = 0.0018). CONCLUSIONS: Alterations in the ECM microenvironment, particularly type I collagen, likely contributes to bladder cancer progression. These findings will open avenues to future functional studies to investigate ECM-tumor interaction as a potential therapeutic intervention to treat NMIBCs.

Original languageEnglish (US)
Pages (from-to)82609-82619
Number of pages11
JournalOncotarget
Volume7
Issue number50
DOIs
StatePublished - 2016

Keywords

  • Bladder cancer
  • Cancer progression
  • Invasion
  • Tumor microenvironment
  • Type I collagen

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Positive association of collagen type I with non-muscle invasive bladder cancer progression'. Together they form a unique fingerprint.

Cite this